Parathyroid adenoma
Last updated: 7 September 2026
Reviewed by: Specialist doctors from the Elfcare quality team
Persistent fatigue, low mood, or a general feeling of being unwell without a clear explanation can be a sign of a parathyroid adenoma. So can kidney stones, bone pain, increased thirst or urination, or being told that your calcium levels are higher than normal on a routine blood test. A parathyroid adenoma is a benign growth in one of the parathyroid glands that causes excess parathyroid hormone production and can affect bone, kidney, and calcium balance throughout the body.
A parathyroid adenoma is the most common cause of primary hyperparathyroidism, accounting for around 80–85% of cases. It is frequently discovered through an elevated calcium level on a routine blood test, often years before it has caused obvious symptoms. Identifying it early allows clinicians to assess for effects on bone and kidney health and determine whether monitoring or surgery is appropriate.
Book a consultation now to test your health
What is a parathyroid adenoma?
The parathyroid glands are four rice-sized glands behind the thyroid that produce parathyroid hormone (PTH), which helps regulate calcium levels in the body. A parathyroid adenoma is a benign growth in one of these glands that causes excess PTH production, even when calcium levels are already high. This leads to primary hyperparathyroidism, a condition that can affect bone strength, kidney health, and calcium balance throughout the body.
Doctors group this condition into two main categories based on how it presents. Primary hyperparathyroidism may be discovered in people with clear symptoms or through routine blood testing in people with few or no specific symptoms. When symptoms are present, they can include kidney stones, bone loss or fractures, increased thirst and urination, abdominal or gastrointestinal symptoms, and muscle weakness.
Many people have no obvious symptoms when the condition is first identified. However, they may still have measurable effects on bone or kidney health, which is why further assessment is important after the biochemical diagnosis.
Symptoms of parathyroid adenoma
Parathyroid adenoma symptoms are often subtle and non-specific, making the condition easy to miss without blood testing. Common signs include:
Persistent fatigue and low energy, one of the most common and frequently overlooked symptoms
Low mood, anxiety, depression, or mild cognitive impairment from hypercalcaemia affecting brain function
Bone pain or tenderness, particularly in the spine, hips, and long bones from calcium being mobilised out of bone
Kidney stones, from excess calcium being excreted in the urine and crystallising in the renal collecting system
Frequent urination and increased thirst from hypercalcaemia impairing renal concentrating ability
Nausea, constipation, and reduced appetite from hypercalcaemia affecting gastrointestinal motility
Muscle weakness and aching, particularly in the proximal limbs
Hypertension, independently associated with primary hyperparathyroidism
In severe or prolonged disease: fragility fractures from significant bone density loss, and nephrocalcinosis from calcium deposition in kidney tissue
What causes parathyroid adenoma?
A parathyroid adenoma develops from the clonal expansion of a single abnormal parathyroid cell that has lost its normal calcium-sensing regulation. Contributing factors include:
Acquired genetic changes: changes within a single parathyroid cell can contribute to adenoma formation.
Past radiation exposure: getting radiation treatments to your head, neck, or chest in the past increases your risk of developing these tumors years later.
Family genes: rare, inherited genetic conditions (like MEN1) can cause multiple parathyroid glands to grow tumors, often alongside growths in other parts of the body.
Age and gender: these tumors are most common in women who have gone through menopause, likely due to how changing hormone levels interact with your body’s calcium controls.
How is a parathyroid adenoma detected?
Parathyroid adenoma is detected through a combination of blood tests identifying the biochemical signature of primary hyperparathyroidism and neck imaging localising the responsible gland before surgery.
Blood tests Elfcare's panel includes the key markers for identifying primary hyperparathyroidism. Relevant markers include:
Calcium (albumin-corrected): elevated calcium is the main biochemical finding that raises suspicion for primary hyperparathyroidism.
Parathyroid hormone (PTH): the key hormone measurement for confirming primary hyperparathyroidism. An elevated or inappropriately normal PTH in the presence of high calcium supports the diagnosis.
Phosphate: usually low because excess hormone forces the kidneys to flush it out of your body.
ALP: elevated levels indicate that chronic hormone overloads are actively breaking down bone tissue.
Creatinine and eGFR: check for kidney damage or strain caused by processing too much calcium.
Vitamin D: Identifies deficiencies that commonly worsen calcium imbalances and require correction.
Magnesium and TSH: screen for mineral or thyroid imbalances that interfere with proper calcium control.
Haemoglobin: checks for anemia, which can sometimes appear alongside chronic illness or genetic syndromes.
Neck MRI Elfcare’s full-body MRI can help visualise the parathyroid region and may identify an enlarged parathyroid gland. While blood tests establish the biochemical diagnosis of primary hyperparathyroidism, imaging helps localise abnormal parathyroid tissue and can support further assessment and treatment planning.
Why early detection matters
Primary hyperparathyroidism damages your body silently over time, eroding bone density, causing painful kidney stones, and increasing heart risks long before you notice obvious symptoms. However, a minor surgery to remove the enlarged gland cures the condition in over 95% of cases, allowing bone and kidney damage to stop immediately. Catching it early through paired blood panels and neck scans uncovers the root cause of chronic fatigue and bone loss, opening the door to a definitive cure that most people miss out on simply because they are never properly diagnosed.
How Elfcare can help
Elfcare's blood panel covers albumin-corrected calcium, phosphate, ALP, vitamin D, kidney function, and magnesium, providing the complete biochemical picture of primary hyperparathyroidism. The combination of elevated corrected calcium with low phosphate is the characteristic pattern that identifies primary hyperparathyroidism and distinguishes it from other causes of hypercalcaemia including malignancy, vitamin D toxicity, and sarcoidosis.
Our neck MRI images the parathyroid region and may help identify enlarged parathyroid glands. Combined with blood tests, it provides complementary information, that is, blood tests identify the biochemical pattern of primary hyperparathyroidism, while imaging helps localise abnormal parathyroid tissue and supports further clinical assessment.
If our blood tests or MRI identify findings consistent with primary hyperparathyroidism or a parathyroid adenoma, we take care of further diagnostics or refer you to the appropriate specialist.
Summary
Parathyroid adenoma is the most common cause of primary hyperparathyroidism, a condition of autonomous PTH excess that drives calcium from bones into the bloodstream, causing progressive bone density loss, kidney stones, cardiovascular risk, and neuropsychiatric symptoms. It is most commonly identified through incidental hypercalcaemia on a routine blood test in an otherwise asymptomatic individual. Elfcare's blood panel identifies the characteristic pattern of elevated calcium with low phosphate and elevated ALP, while our neck MRI images the parathyroid region directly. Early identification and surgical treatment before significant bone loss or renal damage has accumulated results in complete cure in the vast majority of cases, protecting long-term bone density, kidney function, and cardiovascular and neurological health.
Last updated: 7 September 2026
Reviewed by: Specialist doctors from the quality team at Elfcare
FAQ
-
A parathyroid adenoma is a benign tumour of one of the four parathyroid glands, causing autonomous overproduction of parathyroid hormone (PTH) independent of normal calcium regulation. It is the most common cause of primary hyperparathyroidism, a state of chronically elevated PTH and calcium that progressively depletes bone mineral density, damages the kidneys, and affects multiple organ systems. It is most commonly identified through incidental hypercalcaemia on routine blood testing.
-
Persistent fatigue, low mood, cognitive difficulties, bone pain, kidney stones, frequent urination, thirst, nausea, constipation, muscle weakness, and hypertension. Many people have subtle symptoms that are not attributed to the condition for years. The classic description is bones, groans, stones, and moans, referring to bone disease, gastrointestinal symptoms, kidney stones, and neuropsychiatric symptoms respectively.
-
Sporadic parathyroid adenomas arise from somatic mutations causing autonomous PTH secretion. Previous neck radiation increases risk. Multiple endocrine neoplasia type 1 and 2A, and familial isolated hyperparathyroidism, are the most important hereditary causes. Sporadic adenomas are most common in postmenopausal women.
-
Blood tests showing elevated albumin-corrected calcium with low phosphate is the primary biochemical finding. ALP, vitamin D, and kidney function provide the full metabolic picture. Neck MRI identifies the enlarged parathyroid gland directly, providing localisation alongside the biochemical diagnosis.
-
Yes. Elfcare's blood panel covers albumin-corrected calcium, phosphate, ALP, vitamin D, and kidney function, identifying the characteristic biochemical signature of primary hyperparathyroidism. Our neck MRI images the parathyroid region directly. If findings consistent with a parathyroid adenoma are identified, we take care of further diagnostics or refer you to the appropriate specialist.
-
Yes, and surgical removal is curative in over 95% of cases. Minimally invasive parathyroidectomy, guided by pre-operative localisation imaging, removes the responsible adenoma through a small neck incision with low risk and rapid recovery. Calcium and PTH levels normalise within hours of successful surgery. Bone density recovers significantly in the years following curative surgery. Medical management with bisphosphonates and cinacalcet is used when surgery is not possible or declined. Early surgical treatment before significant bone loss or renal damage prevents the long-term consequences that accumulate with each year of untreated primary hyperparathyroidism.